Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Dick Sipkema"'
Autor:
Peter van Rooij, Robert J. Baatenburg de Jong, Henrie van der Est, Inge Noever, David N. Teguh, Aniel Sewnaik, Paul I.M. Schmitz, Peter C. Levendag, Dick Sipkema, Marieke M. Hakkesteegt, Peter W.J. Voet
Publikováno v:
Radiotherapy and Oncology, 89(1), 57-63. Elsevier Ireland Ltd
Background and purpose: Dysphagia is a serious complaint but frequently underreported. This paper assesses for oropharyngeal cancer (OPC) the relationship between the dose received by the swallowing structures, and the findings of a fiberoptic endosc
Autor:
Inger-Karine K. Kolkman-Deurloo, Mark de Langen, Y. Seppenwoolde, Ben J.M. Heijmen, Peter P. Jansen, J. Praag, Dick Sipkema
Publikováno v:
Radiotherapy and Oncology, 86(1), 114-119. Elsevier Ireland Ltd
HDR monotherapy for prostate cancer consists of four fractions. The first fraction is delivered with online TRUS-based treatment planning. For the last three fractions the treatment plan is based on a CT-scan acquired in between fractions 1 and 2. Th
Autor:
Robert J. Baatenburg de Jong, Dick Sipkema, Aniel Sewnaik, Peter W.J. Voet, Daniël de la Bije, Henrie van der Est, Inge Noever, Paul I.M. Schmitz, David N. Teguh, Peter C. Levendag, Peter van Rooij
Publikováno v:
International Journal of Radiation Oncology Biology Physics, 72(4), 1119-1127. Elsevier Inc.
Purpose: To assess the relationship for oropharyngeal (OP) cancer and nasopharyngeal (NP) cancer between the dose received by the swallowing structures and the dysphagia related quality of life (QoL). Methods and Materials: Between 2000 and 2005, 85
Autor:
Inge Noever, Paul I.M. Schmitz, Peter C. Levendag, Marjan van de Pol, Wideke M. Nijdam, Maarten F. de Boer, Cora Braat, Peter P. Jansen, Dick Sipkema
Publikováno v:
International Journal of Radiation Oncology Biology Physics, 59(3), 713-724. Elsevier Inc.
Purpose To report on the tumor control, adverse late normal tissue sequelae, and functional performance in patients with tonsillar fossa and/or soft palate (SP) tumors. The aim of the study is to validate the use of a more selective clinical target v
Autor:
Inger-Karine K. Kolkman-Deurloo, Martin Roos, Wendy M.H. Busser, Shafak Aluwini, Dick Sipkema, Ana Rita Lopes
Publikováno v:
Brachytherapy. 15:S193-S194
Publikováno v:
Radiotherapy and Oncology, 84, S31-S31. Elsevier Ireland Ltd
EUR Research Portal
EUR Research Portal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::de5399b1149ae0f58a45cc955c263368
https://pure.eur.nl/en/publications/7dd9f70b-257c-43df-8552-fe8a981354e7
https://pure.eur.nl/en/publications/7dd9f70b-257c-43df-8552-fe8a981354e7
Autor:
Frank J. Lagerwaard, Connie de Pan, Lars H.P. Murrer, Suresh Senan, Sjaak Burgers, Dick Sipkema
Publikováno v:
Radiotherapy and Oncology, 55, 75-80. Elsevier Ireland Ltd
Radiotherapy and Oncology, 55(1), 75-80. Elsevier Ireland Ltd
Senan, S, Lagerwaard, F J, De Pan, C, Sipkema, D, Burgers, S A & Murrer, L H P 2000, ' A CT-assisted method of dosimetry in brachytherapy of lung cancer ', Radiotherapy and Oncology, vol. 55, no. 1, pp. 75-80 . https://doi.org/10.1016/S0167-8140(00)00157-2
Radiotherapy and Oncology, 55(1), 75-80. Elsevier Ireland Ltd
Senan, S, Lagerwaard, F J, De Pan, C, Sipkema, D, Burgers, S A & Murrer, L H P 2000, ' A CT-assisted method of dosimetry in brachytherapy of lung cancer ', Radiotherapy and Oncology, vol. 55, no. 1, pp. 75-80 . https://doi.org/10.1016/S0167-8140(00)00157-2
Background: The toxicity of endobronchial brachytherapy (EB), in particular fatal haemoptysis and bronchial wall necrosis, has been correlated with the total dose, fraction size, volume encompassed by the 100% isodose, and a proximal tumor location.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::488347c451b93230b88cc78769153c41
https://pure.eur.nl/en/publications/8b224266-2c24-4c0f-88a7-44c66f1da24c
https://pure.eur.nl/en/publications/8b224266-2c24-4c0f-88a7-44c66f1da24c
Autor:
Leo L. Visch, W. M. H. Eijkenboom, Inger-Karine K. Kolkman-Deurloo, Peter P. Jansen, Peter C. Levendag, Andries G. Visser, Paul I.M. Schmitz, Suresh Senan, Dick Sipkema
Publikováno v:
Levendag, P C, Schmitz, P I, Jansen, P P, Eijkenboom, W M, Visser, A G, Kolkman-Deurloo, I K, Sipkema, D, Visch, L L & Senan, S 1998, ' Fractionated high-dose-rate brachytherapy in primary carcinoma of the nasopharynx ', Journal of Clinical Oncology, vol. 16, no. 6, pp. 2213-2220 . https://doi.org/10.1200/JCO.1998.16.6.2213
Journal of Clinical Oncology, 16(6), 2213-2220. American Society of Clinical Oncology
Europe PubMed Central
Journal of Clinical Oncology, 16(6), 2213-2220. American Society of Clinical Oncology
Europe PubMed Central
PURPOSE A growing body of data suggests that local control in nasopharyngeal cancer (NPC) is related to the radiation dose administered. We conducted a single-institution study of high-dose radiotherapy (RT), which incorporated high-dose-rate (HDR) b
Autor:
Dick Sipkema, Cees A. Meeuwis, Leo L. Visch, Connie de Pan, Rob Peters, Peter C. Levendag, Paul I.M. Schmitz
Publikováno v:
Radiotherapy and Oncology, 45, 95-98. Elsevier Ireland Ltd
Introduction : In attempting to improve local tumor control by higher doses of radiation, there has been a resurgence of interest in the implementation of brachytherapy in the management of primary and recurrent cancers of the nasopharynx. Brachyther
Autor:
Paul I.M. Schmitz, Dick Sipkema, Suresh Senan, Peter P. Jansen, W. M. H. Eijkenboom, Cees A. Meeuwis, Andries G. Visser, Peter C. Levendag, Inger Karine Kolkman-Deurloo
Publikováno v:
International Journal of Radiation Oncology Biology Physics, 38(3), 497-506. Elsevier Inc.
Levendag, P C, Schmitz, P I M, Jansen, P P, Senan, S, Eijkenboom, W M H, Sipkema, D, Meeuwis, C A, Kolkman-Deurloo, I K & Visser, A G 1997, ' Fractionated high-dose-rate and pulsed-dose-rate brachytherapy : First clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate ', International Journal of Radiation Oncology Biology Physics, vol. 38, no. 3, pp. 497-506 . https://doi.org/10.1016/S0360-3016(97)00046-1
Levendag, P C, Schmitz, P I M, Jansen, P P, Senan, S, Eijkenboom, W M H, Sipkema, D, Meeuwis, C A, Kolkman-Deurloo, I K & Visser, A G 1997, ' Fractionated high-dose-rate and pulsed-dose-rate brachytherapy : First clinical experience in squamous cell carcinoma of the tonsillar fossa and soft palate ', International Journal of Radiation Oncology Biology Physics, vol. 38, no. 3, pp. 497-506 . https://doi.org/10.1016/S0360-3016(97)00046-1
Purpose: Fractionated high-dose-rate (fr.HDR) and pulsed-dose, rate (PDR) brachytherapy (BT) regimens, which simulate classical continuous low- dose-rate (LDR) interstitial radiation therapy (IRT) schedules, have been developed for clinical use. This